Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03184441 · ClinicalTrials.gov registry record · NA

Premie Pouch to Manage Deformational Plagiocephaly in Very Low Birth Weight Infants

A NA study, sponsored by Boston Children's Hospital.

Completed
Registry status
NA
Development phase
11
Enrollment target

NCT03184441 is a NA study that has completed, run by Boston Children's Hospital. The registered enrollment target is 11 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03184441, a NA study, has completed, sponsored by Boston Children's Hospital.

COMPLETED
Registry status
NA
Development phase
11 participants
Enrollment target

Study Summary

This pilot project proposes to develop and test a new device to manage (defined as resolving, prohibiting, inhibiting or preventing) the development of Deformational Plagiocephaly (DP) in prematurely born infants weighing \< 1 kilogram.

Interventions

  • DEVICE Premie Pouch

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2016-06
Est. Completion 2019-03
Phase NA

Sponsor

Boston Children's Hospital

462 total trials

What the Registry Record Tells You About NCT03184441

The ClinicalTrials.gov registry entry for NCT03184441 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Premie Pouch is the first listed.

NCT03184441 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03184441 about?

NCT03184441 is a clinical study titled "Premie Pouch to Manage Deformational Plagiocephaly in Very Low Birth Weight Infants". This pilot project proposes to develop and test a new device to manage (defined as resolving, prohibiting, inhibiting or preventing) the development of Deformational Plagiocephaly (DP) in prematurely born infants weighing \< 1 kilogram.

What is the current status of trial NCT03184441?

This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2016-06. Estimated completion is 2019-03.

What interventions are being tested in trial NCT03184441?

The interventions under investigation include: Premie Pouch (DEVICE).

Who is sponsoring clinical trial NCT03184441?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.